Grace Therapeutics, Inc. - CL A (ACST)
Historical Portfolio Holders from Q3 2023 to Q2 2024
-
All holders as of June 30, 2024
-
Q2 2024
-
Type / Class
-
Equity / CL A
-
Shares, excl. options Q2 2024
-
2.15M
-
Holdings value Q2 2024
-
$6.3M
-
Value change Q2 2024
-
+$2.59M
-
Grand Portfolio weight change Q2 2024
-
+0%
-
Number of holders
-
12
-
Number of buys Q2 2024
-
0
-
Number of sells Q2 2024
-
0
-
Average buys Q2 2024 %
-
0
-
Average sells Q2 2024 %
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors